UroGen Pharma(URGN) - 2019 Q4 - Earnings Call Transcript

UroGen Pharma Ltd. (NASDAQ:URGN) Q4 2019 Earnings Conference Call March 2, 2020 8:30 AM ET Company Participants Kate Bechtold - Senior Director, Investor Relations Liz Barrett - President and Chief Executive Officer Mark Schoenberg - Chief Medical Officer Peter Pfreundschuh - Chief Financial Officer Jeff Bova - Senior Vice President, Commercial Conference Call Participants Derek Archila - Stifel Nicolaus Chris Howerton - Jefferies Paul Choi - Goldman Sachs Ram Selvaraju - H.C. Wainwright & Co. Matthew Kapla ...